Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain

Infection and Immunity

Volumn 72, Issue 10, 2004, Pages 5840-5849

  Goschnick, M W ^a   Black, C G ^a   Kedzierski, L ^a,c   Holder, A A ^b   Coppel, R L ^a  

^a MONASH UNIVERSITY   (Australia)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 4; MEROZOITE SURFACE PROTEIN 4/5; MEROZOITE SURFACE PROTEIN 5; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL EXPERIMENT; ARTICLE; FEMALE; GENE MUTATION; GENETIC CONSERVATION; GENETIC POLYMORPHISM; IMMUNIZATION; MALARIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIORITY JOURNAL; REDUCTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ESCHERICHIA COLI; FEMALE; MALARIA; MALARIA VACCINES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM; PLASMODIUM YOELII; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; SURVIVAL RATE;

EID: 4644240199     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.10.5840-5849.2004     Document Type: Article

References (35)

1. Anders, R. F., P. E. Crewther, S. Edwards, M. Margetts, M. L. Matthew, B. Pollock, and D. Pye. 1998. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16:240-247.
2. Benjamin, P. A., I. T. Ling, G. Clottey, L. M. Valero, S. A. Ogun, S. L. Fleck, D. Walliker, W. D. Morgan, B. Birdsall, J. Feeney, and A. A. Holder. 1999. Antigenic and sequence diversity at the C terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies. Mol. Biochem. Parasitol. 104:147-156.
3. Black, C. G., and R. L. Coppel. 2000. Synonymous and non-synonymous mutations in a region of the Plasmodium chabaudi genome and evidence for selection acting on a malaria vaccine candidate. Mol. Biochem. Parasitol. 111:447-451.
4. Black, C. G., L. Wang, A. R. Hibbs, E. Werner, and R. L. Coppel. 1999. Identification of the Plasmodium chabaudi homologue of merozoite surface proteins 4 and 5 of Plasmodium falciparum. Infect, Immun. 67:2075-2081.
5. Burns, J. M., C. C. Belk, and P. D. Dunn. 2000. A protective glycosylphosphatidylinositol-anchored membrane protein of Plasmodium yoelii trophozoites and merozoites contains two epidermal growth factor-like domains. Infect. Immun. 68:6189-6195.
6. Clark, I. A., A. C. Allison, and F. E. G. Cox. 1976. Protection of mice against Babesia and Plasmodium with BCG. Nature 259:309-311.
7. Coppel, R. L., K. M. Davern, and M. J. McConville. 1994. Immunochemistry of parasite antigens, p. 475-532. In C. J. van Oss and M. H. V. van Regenmortel (ed.), Immunochemistry. Marcel Dekker Inc., New York, N.Y.
8. Cox, F. E. G. 1970. Protective immunity between malarial parasites and piroplasms in mice. Bull. W. H. O. 43:325-336.
9. Cox, F. E. G., and A. Voller. 1966. Cross-immunity between the malaria parasites of rodents. Ann. Trop. Med. Parasitol. 60:297-303.
10. Crewther, P. E., M. L. Matthew, R. H. Flegg, and R. F. Anders. 1996. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64:3310-3317.
11. Daly, T. M., J. M. Burns, and C. A. Long. 1992. Comparison of the carboxy terminal, cysteine-rich domain of the merozoite surface protein 1 from several strains of Plasmodium yoelii. Mol. Biochem. Parasitol. 52:279-282.
12. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
13. Hughes, M. K., and A. L. Hughes. 1995. Natural selection on Plasmodium surface proteins. Mol. Biochem. Parasitol. 71:99-113.
14. Jongwutiwes, S., K. Tanabe, and H. Kanbara. 1993. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 59:95-100.
15. Kang, Y., and C. A. Long. 1995. Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Mol. Biochem. Parasitol. 73:103-110.
16. Kedzierski, L., C. G. Black, and R. L. Coppel. 2000. Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii. Mol. Biochem. Parasitol. 105:137-147.
17. Kedzierski, L., C. G. Black, and R. L. Coppel. 2000. Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge. Infect. Immun. 68:6034-6037.
18. Kedzierski, L., C. G. Black, M. W. Goschnick, A. W. Stowers, and R. L. Coppel. 2002. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii. Infect. Immun. 70:6606-6613.
19. Kedzierski, L., C. G. Black, A. W. Stowers, M. W. Goschnick, D. C. Kaslow, and R L. Coppel. 2001. Comparison of the protective efficacy of yeast-derived and E. coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yodil Vaccine 19:4661-4668.
20. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasitol. Immunol. 16:63-67.
21. Majarian, L. H., T. M. Daly, W. P. Weindanz, and C. A. Long. 1984. Passive immunization against marine malaria with an IgG3 monoclonal antibody. J. Immunol. 132:3131-3137.
22. Marshall, V. M., A. Suva, M. Foley, S. Cranmer, L. Wang, D. J. McColl, D. J. Kemp, and R. L. Coppel. 1997. A second merozoite surface protein (MSP4) of Plasmodium falciparum that contains an epidermal growth factor-like domain. Infect. Immun. 65:4460-4467.
23. Marshall, V. M., L. X. Zhang, R. F. Anders, and R. L. Coppel. 1996. Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum. Mol. Biochem. Parasitol. 77:109-113.
24. McColm, A. A., and L. Dalton. 1983. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection. Ann. Trop. Med. Parasitol. 77:355-377.
25. Miller, L. H., T. Roberts, M. Shahabuddin, and T. F. McCutchan. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein (MSP-1). Mol. Biochem. Parasitol. 59:1-14.
26. Nussenzweig, R. S., and C. A. Long. 1994. Malaria vaccines: multiple targets. Science 265:1381-1383.
27. Qari, S. H., Y. P. Shi, I. F. Goldman, B. L. Nahlen, M. Tibayrene, and A. A. Lal. 1998. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein 1 (MSP-1), a potential malaria vaccine antigen. Mol. Biochem. Parasitol. 92:241-252.
28. Renia, L., I. T. Ling, M. Marussig, F. Miltgen, A. A. Holder, and D. Mazier. 1997. Immunization with a recombinant C-terminal fragment of Plasmodium yoeiii merozoite surface protein 1 protects mice against homologous but not heterologous P, yoelii sporozoite challenge. Infect. Immun. 65:4419-4423.
29. Rotman, H. L.,T. M. Daly, and C. A. Long. 1999. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. Exp. Parasitol. 91:78-85.
30. Sachs, J., and P. Malaney. 2002. The economic and social burden of malaria. Nature 415:680-685.
31. Thomas, A. W., A. P. Waters, and D. Carr. 1990. Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium faldparum. Mol. Biochem. Parasitol. 42:285-288.
32. Tolle, R., H. Bujard, and J. A. Cooper. 1995. Plasmodium falciparum: variations within the C-terminal region of merozoite surface antigen-1, Exp. Parasitol. 81:47-54.
33. Wang, L., C. G. Black, V. M. Marshall, and R. L. Coppel. 1999. Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum. Infect. Immun. 67:2193-2200.
34. Wang, L., V. M. Marshall, and R. L. Coppel. 2002. Limited polymorphism of the vaccine candidate merozoite surface protein 4 of Plasmodium falciparum. Mol. Biochem. Parasitol. 120:301-303.
35. Wu, T., C. G. Black, L. Wang, A. R. Hibbs, and R. L. Coppel. 1999. Lack of sequence diversity in the gene encoding merozoite surface protein 5 of Plasmodium falciparum. Mol. Biochem. Parasitol. 103:243-250.